AI 탑재 영상 워크플로우 플랫폼 시장 예측(-2032년) : 컴포넌트별, 모달리티별, 용도별, 최종사용자별, 지역별 세계 분석

According to Stratistics MRC, the Global AI-Powered Imaging Workflow Platforms Market is accounted for $1.1 billion in 2025 and is expected to reach $7.8 billion by 2032 growing at a CAGR of 33% during the forecast period. AI-powered imaging workflow platforms are integrated software and hardware solutions that use artificial intelligence to manage, analyze, and interpret medical imaging data. These platforms automate tasks such as scheduling, image routing, anomaly detection, and preliminary report generation, improving screening efficiency and diagnostic accuracy. They help radiologists and clinicians prioritize urgent cases, reduce administrative workload, and enhance clinical decision-making in radiology and pathology.

According to the Bank for International Settlements, consortium-based AI models that analyze transaction patterns across multiple banks are significantly more effective at detecting sophisticated, cross-institutional payment fraud.

Market Dynamics:

Driver:

Rising demand to streamline radiology workflows

Rising pressure on radiology departments to manage increasing scan volumes is driving strong adoption of AI-powered workflow platforms. Hospitals seek automated triage, faster image routing, and intelligent workload balancing to reduce bottlenecks and improve patient throughput. AI tools accelerate reading times, flag urgent cases, and integrate seamlessly with PACS/RIS platforms. As radiologists face rising burnout and staffing shortages, workflow automation becomes a mission-critical enabler of efficiency, operational resilience, and diagnostic consistency across medical imaging ecosystems.

Restraint:

Opaque AI decision models limiting clinician trust

A key restraint is the limited interpretability of AI decision pathways, which often function as "black boxes," reducing clinician confidence in automated recommendations. Radiologists require transparent evidence trails, explainable outputs, and validated reasoning to integrate AI into diagnostic routines safely. Regulatory bodies increasingly emphasize explainability, adding additional validation layers that slow adoption. Without robust interpretability frameworks, AI workflow platforms face hesitation from clinical stakeholders, especially in high-stakes diagnostic environments where accountability and accuracy are paramount.

Opportunity:

Integration of multimodal diagnostics

A major opportunity lies in unifying multimodal diagnostic data-integrating imaging, pathology, genomics, and clinical records into a single AI-powered workflow layer. This fusion enables holistic diagnostic reasoning, allowing platforms to deliver richer, more context-aware insights. Multimodal integration improves early disease detection, enhances triage precision, and supports personalized care pathways. As healthcare shifts toward unified diagnostic ecosystems, AI solutions capable of synthesizing diverse data streams become essential, driving demand for next-generation imaging workflow platforms.

Threat:

Rapid algorithm obsolescence

Rapid algorithm obsolescence poses a growing threat as imaging technologies, acquisition protocols, and clinical standards evolve faster than many AI models can be retrained. Outdated algorithms risk performance degradation, missed anomalies, or bias drift, eroding clinical trust. Vendors must invest continuously in dataset updates, regulatory revalidations, and adaptive learning infrastructures. Failure to maintain algorithm currency can result in competitive displacement and reduced platform reliability, especially in hospitals seeking future-proof AI systems with continuous performance optimization.

Covid-19 Impact:

COVID-19 accelerated the digitization of radiology services, significantly boosting adoption of AI workflow platforms to manage surging imaging demands and reduced onsite staffing. AI-enabled triage for chest CTs and X-rays became critical for rapid COVID severity assessment, streamlining clinical decision-making. Remote reading and cloud-based imaging collaboration expanded sharply, reinforcing long-term interest in automated workflows. The pandemic ultimately highlighted the value of AI-driven efficiency, cementing these platforms as essential tools in post-pandemic radiology operations.

The software platforms segment is expected to be the largest during the forecast period

The software platforms segment is expected to command the largest market share, resulting from widespread deployment of AI engines that automate triage, image prioritization, report structuring, and workflow orchestration. Hospitals increasingly adopt centralized platforms that integrate with existing PACS/RIS systems, minimizing operational disruption. These solutions provide continuous upgrades, scalable processing, and cross-modality compatibility, making them foundational to digital radiology ecosystems. Their versatility across diagnostic pathways further reinforces their leadership in the global market.

The MRI segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the MRI segment is predicted to witness the highest growth rate, propelled by the rising need to accelerate long scan times and optimize interpretation workflows. AI platforms enhance MRI throughput by automating protocol selection, noise reduction, segmentation, and quantitative analysis. As MRI usage grows in neurology, oncology, and musculoskeletal care, demand for AI support tools intensifies. AI-driven MRI acceleration and reconstruction algorithms further stimulate adoption, positioning this modality as the fastest-growing user base for workflow platforms.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, attributed to rapid expansion of diagnostic imaging infrastructure, rising patient volumes, and strong government support for AI-driven healthcare modernization. Countries such as China, Japan, South Korea, and India are investing heavily in smart hospitals and radiology digitization. Growing AI innovation hubs and increasing adoption of cloud-based imaging platforms reinforce the region's dominance. These factors collectively accelerate deployment of workflow automation technologies across APAC healthcare systems.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR associated with early adoption of advanced radiology IT systems, strong regulatory frameworks for AI validation, and mature hospital digitization. The presence of leading AI developers, substantial investment in clinical automation, and widespread integration with PACS/RIS ecosystems accelerates growth. Rising focus on workflow efficiency, shortage of radiologists, and expanding reimbursement pathways for AI-supported imaging further support rapid market expansion in the region.

Key players in the market

Some of the key players in AI-Powered Imaging Workflow Platforms Market include Siemens Healthineers, GE HealthCare, Philips, IBM, Nuance, Viz.ai, Aidoc, Zebra Medical Vision, Arterys, Agfa Healthcare, Qure.ai, Canon Medical, Fujifilm, Riverain Technologies, Imagen Technologies, and Butterfly Network.

Key Developments:

In August 2025, GE HealthCare introduced the Edison Workflow Orchestrator, a vendor-agnostic platform that uses predictive AI to allocate reading assignments across a radiology department in real-time based on radiologist subspecialty, current workload, and exam complexity, reducing report turnaround times by over 20%.

In July 2025, Viz.ai received FDA clearance for its Viz TAVR platform, which uses AI to automatically analyze CT scans for structural heart disease, identify eligible patients for Transcatheter Aortic Valve Replacement (TAVR), and instantly notify the heart team, streamlining the pre-procedural workflow.

In June 2025, Philips announced the Enterprise Radiology Performance Suite, a cloud-native platform that leverages AI to provide health systems with a real-time dashboard of key performance indicators (KPIs), predicting bottlenecks and recommending resource shifts to optimize departmental efficiency.

Components Covered:

• Software Platforms
• AI Analytics Modules
• Workflow Optimization Engines
• Reporting & Visualization Tools
• Integration & Middleware Solutions

Modalities Covered:

• MRI
• CT
• Ultrasound
• X-Ray & Fluoroscopy
• PET & Nuclear Imaging

Applications Covered:

• Diagnostic Workflow Automation
• Clinical Decision Support
• Image Triage & Prioritization
• Quality Control & Error Reduction
• Radiology Reporting Optimization

End Users Covered:

• Hospitals
• Diagnostic Centers
• Research Institutions
• AI Health-Tech Companies
• Radiology Groups & Networks

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Application Analysis
• 3.7 End User Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global AI-Powered Imaging Workflow Platforms Market, By Component

• 5.1 Introduction
• 5.2 Software Platforms
• 5.3 AI Analytics Modules
• 5.4 Workflow Optimization Engines
• 5.5 Reporting & Visualization Tools
• 5.6 Integration & Middleware Solutions

6 Global AI-Powered Imaging Workflow Platforms Market, By Modality

• 6.1 Introduction
• 6.2 MRI
• 6.3 CT
• 6.4 Ultrasound
• 6.5 X-Ray & Fluoroscopy
• 6.6 PET & Nuclear Imaging

7 Global AI-Powered Imaging Workflow Platforms Market, By Application

• 7.1 Introduction
• 7.2 Diagnostic Workflow Automation
• 7.3 Clinical Decision Support
• 7.4 Image Triage & Prioritization
• 7.5 Quality Control & Error Reduction
• 7.6 Radiology Reporting Optimization

8 Global AI-Powered Imaging Workflow Platforms Market, By End User

• 8.1 Introduction
• 8.2 Hospitals
• 8.3 Diagnostic Centers
• 8.4 Research Institutions
• 8.5 AI Health-Tech Companies
• 8.6 Radiology Groups & Networks

9 Global AI-Powered Imaging Workflow Platforms Market, By Geography

• 9.1 Introduction
• 9.2 North America
  • 9.2.1 US
  • 9.2.2 Canada
  • 9.2.3 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 Italy
  • 9.3.4 France
  • 9.3.5 Spain
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 New Zealand
  • 9.4.6 South Korea
  • 9.4.7 Rest of Asia Pacific
• 9.5 South America
  • 9.5.1 Argentina
  • 9.5.2 Brazil
  • 9.5.3 Chile
  • 9.5.4 Rest of South America
• 9.6 Middle East & Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 UAE
  • 9.6.3 Qatar
  • 9.6.4 South Africa
  • 9.6.5 Rest of Middle East & Africa

10 Key Developments

• 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 10.2 Acquisitions & Mergers
• 10.3 New Product Launch
• 10.4 Expansions
• 10.5 Other Key Strategies

11 Company Profiling

• 11.1 Siemens Healthineers
• 11.2 GE HealthCare
• 11.3 Philips
• 11.4 IBM
• 11.5 Nuance
• 11.6 Viz.ai
• 11.7 Aidoc
• 11.8 Zebra Medical Vision
• 11.9 Arterys
• 11.10 Agfa Healthcare
• 11.11 Qure.ai
• 11.12 Canon Medical
• 11.13 Fujifilm
• 11.14 Riverain Technologies
• 11.15 Imagen Technologies
• 11.16 Butterfly Network